;){kind=link}
Mr. Han
Merchandising Mgr.
International Business Department
Address:
19th Floor Fortune Building, No. 9 Honghu East Road, Yubei District, Chongqing, China
Telephone:
Zip Code:
Fax:
| Please sign in to view contact details |
Account Registered in:
2014
Business Range:
Health & Medicine
Management System Certification:
GMP
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
Southwest Synthetic Pharmaceutical Corp., Ltd. (Stock code on Shenzhen Stock Exchange: 000788) is located in Chongqing, China. It is the largest manufacturing, R&D and export enterprise of biopharmaceutical and synthetic pharmaceutical active pharmaceutical ingredients (APIs) and pharmaceutical preparations in westernChina. Southwest Synthetic Pharmaceutical Corp., Ltd. Is also the key enterprise ...
Southwest Synthetic Pharmaceutical Corp., Ltd. (Stock code on Shenzhen Stock Exchange: 000788) is located in Chongqing, China. It is the largest manufacturing, R&D and export enterprise of biopharmaceutical and synthetic pharmaceutical active pharmaceutical ingredients (APIs) and pharmaceutical preparations in westernChina. Southwest Synthetic Pharmaceutical Corp., Ltd. Is also the key enterprise of Chinese pharmaceutical industry, national innovative pilot enterprise, key high and new tech enterprise of national Torch Program, the brand leader enterprise supported byChongqinggovernment. It is the biggest Lovastatin and Sulfonamides manufacturing enterprise in the world.
In 2009, Southwest Synthetic Pharmaceutical Corp., Ltd. Acquired Chongqing Daxin Pharmaceutical Co., Ltd. Through directional add-issuance. In 2011, Southwest Synthetic Pharmaceutical Corp., Ltd acquired Beijing Beiyi Pharmaceutical Co., Ltd. Through directional add-issuance, in this way, Southwest Synthetic Pharmaceutical Corp., Ltd. Expanded its business from pharmaceutical manufacturing to pharmaceutical circulation and built a national sales circulation platform with core areas ofShanghai, Beijing, WuhanandChongqing.
Southwest Synthetic Pharmaceutical Corp., Ltd. Boasts several large-scale pharmaceutical manufacturing bases, including a modernized pharmaceutical site in Chongqing Liangjiang New Area, which meets international cGMP standards. It has hundreds of APIs and preparations which span more than 20 categories, including antimicrobials, cardiovascular treatments, vitamins, anti-inflammatories, immunosuppressive products and plasma volume expanders.
Southwest Synthetic Pharmaceutical Corp., Ltd. Is one of the top pharmaceutical enterprises owning the most certifications inChina. All products of this company have been cGMP certified. Twenty products have US DMFs and twelve products have been the subject of successful US FDA site inspections. Seven products have been granted CEP.
Southwest Synthetic Pharmaceutical Corp., Ltd. Boasts a national-level technology center which is dedicated to developing new products and new technologies. Many senior professional technicians enjoy special funding by the State Council in recognition of their contribution to science, research and industry.
In 2009, Southwest Synthetic Pharmaceutical Corp., Ltd. Acquired Chongqing Daxin Pharmaceutical Co., Ltd. Through directional add-issuance. In 2011, Southwest Synthetic Pharmaceutical Corp., Ltd acquired Beijing Beiyi Pharmaceutical Co., Ltd. Through directional add-issuance, in this way, Southwest Synthetic Pharmaceutical Corp., Ltd. Expanded its business from pharmaceutical manufacturing to pharmaceutical circulation and built a national sales circulation platform with core areas ofShanghai, Beijing, WuhanandChongqing.
Southwest Synthetic Pharmaceutical Corp., Ltd. Boasts several large-scale pharmaceutical manufacturing bases, including a modernized pharmaceutical site in Chongqing Liangjiang New Area, which meets international cGMP standards. It has hundreds of APIs and preparations which span more than 20 categories, including antimicrobials, cardiovascular treatments, vitamins, anti-inflammatories, immunosuppressive products and plasma volume expanders.
Southwest Synthetic Pharmaceutical Corp., Ltd. Is one of the top pharmaceutical enterprises owning the most certifications inChina. All products of this company have been cGMP certified. Twenty products have US DMFs and twelve products have been the subject of successful US FDA site inspections. Seven products have been granted CEP.
Southwest Synthetic Pharmaceutical Corp., Ltd. Boasts a national-level technology center which is dedicated to developing new products and new technologies. Many senior professional technicians enjoy special funding by the State Council in recognition of their contribution to science, research and industry.
International Commercial Terms(Incoterms):
CIF, DDP
Terms of Payment:
LC, T/T
Number of Foreign Trading Staff:
21~50 People
Main Customer(s):
| Company Name | Country/Region | Products You Supply |
|---|---|---|
| PAR | United States | API Pharmaceuticals |
| Aurobindo | India | API Pharmaceuticals |
| Pfizer | China | API Pharmaceuticals |
| Johnson & Johnson | United States | Vitamin |
| Novatis | United Kingdom | API Pharmaceuticals |
Export Year:
2000-01-01
Export Percentage:
21%~30%
Main Markets:
North America, South America, Western Europe
Nearest Port:
Shanghai
Factory Address:
19th Floor Fortune Building, No. 9 Honghu East Road, Yubei District, Chongqing, China
No. of R&D Staff:
Above 50 People
No. of Production Lines:
Above 10
Annual Output Value:
Above US$100 Million